Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders
- 1 April 1999
- journal article
- review article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 133 (4) , 321-325
- https://doi.org/10.1016/s0022-2143(99)90061-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The role of oxidized lipoproteins in atherogenesisPublished by Elsevier ,1999
- Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosisCurrent Opinion in Lipidology, 1997
- Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)The Lancet, 1996
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994
- Role of oxidized low density lipoprotein in atherogenesis.Journal of Clinical Investigation, 1991
- Leukocytic Oxygen Activation and Microbicidal Oxidative ToxinCritical Reviews in Biochemistry and Molecular Biology, 1989
- Myeloperoxidase DeficiencyHematology/Oncology Clinics of North America, 1988
- [40] Preparation and characterization of chloraminesPublished by Elsevier ,1986
- Oxygen Metabolism and the Toxic Properties of PhagocytesAnnals of Internal Medicine, 1980
- Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol depositionProceedings of the National Academy of Sciences, 1979